[1]冯 磊,常春红,管晓卿,等.宫颈癌患者血浆miRNA-10b的表达及其临床意义[J].现代检验医学杂志,2018,33(01):52-55,58.[doi:10.3969/j.issn.1671-7414.2018.01.001]
　FENG Lei,CHANG Chun-hong,GUAN Xiao-qing,et al.Expression of Plasma miRNA-10b in Patients with Cervical Cancer and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2018,33(01):52-55,58.[doi:10.3969/j.issn.1671-7414.2018.01.001]
点击复制

宫颈癌患者血浆miRNA-10b的表达及其临床意义()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年01期
页码:
52-55,58
栏目:
论著
出版日期:
2018-02-05

文章信息/Info

Title:
Expression of Plasma miRNA-10b in Patients with Cervical Cancer and Its Clinical Significance
文章编号:
1671-7414(2018)01-052-05
作者:
冯 磊; 常春红; 管晓卿; 汪新宇; 郭甜静
涿州市医院妇产科,河北涿州 072750
Author(s):
FENG Lei; CHANG Chun-hong; GUAN Xiao-qing; WANG Xin-yu; GUO Tian-jing
Department of Obstetrics and Gynecology,Zhuozhou City Hospital,Hebei Zhuozhou 072750,China
关键词:
微小核糖核酸-10b;  宫颈癌;  宫颈上皮内瘤样病变;  敏感性与特异性
分类号:
R737.33; R730.43
DOI:
10.3969/j.issn.1671-7414.2018.01.001
文献标志码:
A
摘要:
目的 探讨血浆微小核糖核酸-10b(miRNA-10b)在宫颈癌患者中的表达及其临床意义。方法 采用RT-PCR检测168例宫颈癌患者,68例宫颈上皮内瘤样病变(CIN)患者(CIN组)和45例健康女性(对照组)血浆miRNA-10b,鳞癌抗原(SCCA)及癌胚抗原(CEA)表达水平,分析miRNA-10b表达与宫颈癌临床病理特征的关系。应用ROC曲线评价miRNA-10b,SCCA及CEA对宫颈癌诊断的灵敏度和特异度,多元Logistic回归模型分析三项指标与宫颈癌的关系。Pearson相关分析宫颈癌患者血浆miRNA-10b与SCCA和CEA的相关性。结果 宫颈癌组血浆miRNA-10b,SCCA及CEA表达水平均明显高于CIN组和对照组[miRNA-10b(2-ΔΔCt):5.83±1.84 vs 2.64±0.92和2.38±0.75; SCCA(ng/ml):8.74±2.26 vs 1.97±0.62和0.61±0.15; CEA(ng/ml):5.71±2.15 vs 1.56±0.58和1.34±0.16,F=17.842,13.614,8.273,均P<0.01]。宫颈癌患者血浆miRNA-10b表达水平与临床分期、淋巴结转移、浸润深度及SCCA水平相关(t/F值=19.287,21.528,5.672,5.284,均P<0.05)。血浆miRNA-10b,SCCA,CEA及三项联合诊断宫颈癌的AUC(95%CI)分别为0.836(0.752～0.924),0.795(0.722～0.875),0.664(0.596～0.738)和0.882(0.794～0.958),其最佳截值分别为4.26,6.58 ng/ml和4.05 ng/ml。Logistic回归分析显示,血浆miRNA-10b和SCCA水平升高是宫颈癌发生的独立危险因素[OR(95%CI)=1.816(1.629～2.483),1.427(1.206～1.975)]。宫颈癌患者血浆miRNA-10b与SCCA呈正相关(r=0.637,P<0.01)。结论 血浆miRNA-10b有望作为早期诊断宫颈癌的分子标志物,与SCCA和CEA联合应用可提高宫颈癌诊断的准确性。
Abstract:
Abstract:Objective To investigate the expression and clinical significance of plasma microRNA-10b(miRNA-10b)in patients with cervical cancer.Methods The levels of plasma miRNA-10b, SCCAand CEA were detected by RT-PCR in 168 patients with cervical cancer,68 patients with CIN(CIN group)and 45 healthy women(control group),analyzed the relation between miRNA-10b expression and clinicopathological features of cervical cancer.The sensitivity and specificity of miRNA-10b,SCCA and CEA in the diagnosis of cervical cancer were evaluated by ROC curve,and the relationship betweenthree indexes and cervical cancer were analyzed by multivariate Logistic regression model.Correlation analysis of plasma miRNA-10b and SCCA,CEA in patients with cervical cancer was analysed by Pearson.Results The levels of miRNA-10b, SCCA and CEA in the cervical cancer group were significantly higher than those in the CIN group and the control group[miRNA-10b(2-ΔΔCt):5.83±1.84 vs 2.64±0.92 and 2.38±0.75; SCCA(ng/ml):8.74±2.26 vs 1.97±0.62 and 0.61±0.15; CEA(ng/ml):5.71±2.15 vs 1.56±0.58 and 1.34±0.16,F=17.842,13.614,8.273,all P<0.01].The level of plasma miRNA-10b expression was correlated with clinical stage,lymphnode metastasis,depth of invasion and SCCA level in patients with cervical cancer(t/F=19.287,21.528,5.672,5.284,P<0.05).Plasma miRNA-10b,SCCAand CEA and three combined diagnosis of cervical cancer of AUC(95%CI)were 0.836(0.752～0.924),0.795(0.722～0.875),0.664(0.596～0.738)and 0.882(0.794～0.958),respectively.The optimal cut-off values were 4.26,6.58 ng/ml and 4.05 ng/ml,respectively.Logistic regression analysis showed that elevated plasma miRNA-10b and SCCA levels were independent risk factors for cervical cancer[OR(95%CI)=1.816(1.629～2.483),OR(95%CI)=1.427(1.206～1.975)].Plasma miRNA-10b was positively correlated with SCCA in patients with cervical cancer(r=0.637,P<0.01).Conclusion Plasma miRNA-10b will be expectedto be a molecular marker for the early diagnosis of cervical cancer.The combination of SCCA and CEA can improve the diagnostic accuracy of cervical cancer.

参考文献/References:

[1] Suh DH,Kim JW,Kang S,et al.Major clinical research advances in gynecologic cancer in 2013[J].J Gynecol Oncol,2014,25(3):236-248. 2] M'hamed IF,Privat M,Ponelle F,et al.Identification of miR-10b,miR-26a,miR-146a and miR-153 as potential triple-negative breast cancer biomarkers[J].Cell Oncol(Dordr),2015,38(6):433-442.
[3] Wang Y,Li Z,Zhao X,et al.miR-10b promotes invasion by targeting HOXD10 in colorectal cancer[J].Oncol Lett,2016,12(1):488-494.
[4] Shi LX,Zhang L,Wang CY,et al.Expression of serum microRNA-378 and itsclinical significance in renal cell carcinoma[J].Genet Mol Biol,2017,40(2):525-529.
[5] Chen AH,Qin YE,Tang WF,et al.MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer[J].Cancer Cell Int,2017,9(6):1-9.
[6] Yang YL,Xu LP,Zhuo FL,et al.Prognostic value of microRNA-10b overexpression in peripheral blood mononuclear cells of nonsmall-cell lung cancer patients[J].Tumour Biol,2015,36(9):7069-7075.
[7] Liang AL,Zhang TT,Zhou N,et al.MiRNA-10b sponge:An anti-breast cancer study in vitro[J].Oncol Rep,2016,35(4):1950-1958.
[8] Hou R,Wang D,Lu J,et al.MicroRNA-10b inhibits proliferation, migration and invasion in cervical cancer cells via direct targeting of insulin-likegrowth factor-1 receptor[J].Oncol Lett,
[9] Li M,Li BY,Xia H,et al.Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis[J].Eur Rev Med Pharmacol Sci,2017,21(10):2346-2350.
[10] Zou D,Zhou Q,Wang D,et al.The downregulation of microRNA-10b and its role in cervical cancer[J].Oncol Res,2016,24(2):99-108.
[11] Wang N,Chen P,Huang LP,et al.Prognostic significance of microRNA-10b overexpression in breast cancer:a meta-analysis[J].Genet Mol Res,2016,15(2):7350-7359.
[12] Parrella P,Barbano R,Pasculli B,et al.Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients[J].Mol Cancer,2014,13(1):142.
[13] Saldanha G,Elshaw S,Sachs P,et al.MicroRNA-10b is a prognostic biomarker for melanoma[J].Mod Pathol,2016,29(2):112-121.
[14] Eissa S,Matboli M,Shehata HH,et al.MicroRNA-10b and minichromosomemaintenance complex component 5 gene as prognostic biomarkers in breast cancer[J].Tumour Biol,2015,36(6):4487-4494.
[15] Chen WJ,Cai FF,Zhang B,et al.The level of circulating miRNA-10b andmiRNA-373 in detecting lymph node metastasis of breast cancer:potential biomarkers[J].Tumour Biol,2013,34(1):455-462. 收稿日期:2017-08-31 修回日期:2017-09-29

相似文献/References:

[1]王 妍,黄钦贤,林章礼,等.汕头地区女性HPV的感染状况回顾[J].现代检验医学杂志,2015,30(04):122.[doi:10.3969/j.issn.1671-7414.2015.04.036]
　WANG Yan,HUANG Qin-xian,LIN Zhang-li,et al.Review of HPV Infection Status of the Women in Shantou Region[J].Journal of Modern Laboratory Medicine,2015,30(01):122.[doi:10.3969/j.issn.1671-7414.2015.04.036]
[2]原荣,李军,王一羽,等.陕西省榆林地区和商洛地区HPV感染及亚型分布对比研究[J].现代检验医学杂志,2016,31(06):48.[doi:10.3969/j.issn.1671-7414.2016.06.013]
　YUAN Rong,LI Jun,WANG Yi-yu,et al.Study on HPV Infection Rate and Hypotype Distribution between Yulin and Shangluo Area in Shaanxi Province[J].Journal of Modern Laboratory Medicine,2016,31(01):48.[doi:10.3969/j.issn.1671-7414.2016.06.013]
[3]王 冰,朱月蓉,何玉杰,等.血清结合珠蛋白在宫颈癌诊断中的应用研究[J].现代检验医学杂志,2017,32(01):106.[doi:10.3969/j.issn.1671-7414.2017.01.029]
　WANG Bing,ZHU Yue-rong,HE Yu-jie,et al.Application of Haptoglobin in Cervical Cancer Diagnosis[J].Journal of Modern Laboratory Medicine,2017,32(01):106.[doi:10.3969/j.issn.1671-7414.2017.01.029]
[4]原 荣,李 军,南 星,等.陕西省安康和延安两地区妇女HPV感染及型别分布对比研究[J].现代检验医学杂志,2017,32(02):64.[doi:10.3969/j.issn.1671-7414.2017.02.017]
　YUAN Rong,LI Jun,NAN Xing,et al.Comparative Study on HPV Infection and Hypotype Distribution between Ankang and Yan'an Area of Shaanxi Province[J].Journal of Modern Laboratory Medicine,2017,32(01):64.[doi:10.3969/j.issn.1671-7414.2017.02.017]
[5]林金端a,刘红伟a,张欣宁b,等.Mybl2在不同病变程度宫颈组织中的表达[J].现代检验医学杂志,2017,32(02):141.[doi:10.3969/j.issn.1671-7414.2017.02.039]
　LIN Jin-duana,LIU Hong-weia,ZHANG Xin-ningb,et al.Expression Level and Clinical Significance of Mybl2 in Cervical Tissues[J].Journal of Modern Laboratory Medicine,2017,32(01):141.[doi:10.3969/j.issn.1671-7414.2017.02.039]
[6]林丽慧,唐 梅,于春玲,等.HPV阳性宫颈癌和CIN患者血浆miR-150,SCCA及CA125的表达及临床意义[J].现代检验医学杂志,2018,33(02):62.[doi:10.3969/j.issn.1671-7414.2018.02.001]
　LIN Li-hui,TANG Mei,YU Chun-ling,et al.Expression and Clinical Significance of Plasma miR-150,SCCA and CA125 in Patients with HPV Positive Cervical Cancer and CIN[J].Journal of Modern Laboratory Medicine,2018,33(01):62.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[7]刘 娅,贺 巧,佘佳琪.宫颈癌患者治疗前血浆凝血四项指标与生存率的相关性研究[J].现代检验医学杂志,2019,34(03):137.[doi:10.3969/j.issn.1671-7414.2019.03.035]
　LIU Ya,HE Qiao,SHE Jia-qi.Correlation between the Four Indicators of Coagulation andPrognosis in Patients with Cervical Carcinoma before Treatment[J].Journal of Modern Laboratory Medicine,2019,34(01):137.[doi:10.3969/j.issn.1671-7414.2019.03.035]

备注/Memo

备注/Memo:
基金项目:保定市科学计划与发展指导计划项目(16ZF196)。 作者简介:冯 磊(1971-),女,本科,主治医师,主要从事临床妇产科疾病研究,E-mail:18003123880@163.com。
更新日期/Last Update: 2018-02-07